Medindia

X

Orchid Cellmark to Announce Third Quarter 2007 Financial Results on November 1, 2007

Monday, October 15, 2007 General News J E 4
Advertisement
PRINCETON, N.J., Oct. 15 Orchid Cellmark Inc.(Nasdaq: ORCH), a leading worldwide provider of identity DNA testing services,will release its third quarter 2007 financial results on Thursday, November 1,2007 at approximately 7:00 am EDT, and is hosting a conference call andwebcast to discuss the results at 10:00 a.m. EDT on the same day. Managementwill discuss financial results for the third quarter 2007 as well as operatinghighlights. A question-and-answer session will follow management'sdiscussion. All interested parties are encouraged to listen to the liveconference call or the live or archived webcast.

About Orchid Cellmark

Orchid Cellmark is a leading provider of identity DNA testing services forthe human identity and agriculture markets. In the human identity area, thecompany provides DNA testing services for forensic, family relationship andsecurity applications. In the agriculture field, Orchid Cellmark provides DNAtesting services for selective trait breeding. Orchid Cellmark's strongmarket positions in these segments reflect the company's accreditedlaboratories in the U.S. and U.K., its innovative genetic analysistechnologies and expertise, and the world-renowned Cellmark brand that hasbeen associated with exceptional quality, reliability and customer service fornearly two decades. More information on Orchid Cellmark can be found atwww.orchid.com.Conference Call Details Date and Time: Thursday, November 1, 2007 at 10:00am EDT Dial-In: US/Canada: (877) 266-0703 Int'l/Local: (706) 643-7682 Conference ID: 20685333 Webcast: Live webcast and replay available via the Investor Relations section of the company's website at www.orchid.com. The webcast will be available for 90 days.

SOURCE Orchid Cellmark Inc.
Advertisement


Advertisement

You May Also Like

Advertisement
View All

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
User Avatar
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions
s
NicOx Opens U.S. Headquarters in New Jersey
S
Facet Solution's AFRS(TM) Implant Demonstrates Pos...